These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A new take on prostate drugs. Johns Hopkins Med Lett Health After 50; 1998 Apr; 10(2):1-2. PubMed ID: 9552801 [No Abstract] [Full Text] [Related]
23. New tests for prostate cancer may be nearing the clinic. Tuma RS J Natl Cancer Inst; 2010 Jun; 102(11):752-4. PubMed ID: 20498428 [No Abstract] [Full Text] [Related]
24. Benign prostatic hyperplasia: maximizing treatment with alpha blockers. Lowenthal DT; Flannery M; Mader SL; Nelson RP Geriatrics; 1998 Oct; 53 Suppl 2():S4-28. PubMed ID: 9789482 [No Abstract] [Full Text] [Related]
25. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia. DiSantostefano RL; Biddle AK; Lavelle JP BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339 [TBL] [Abstract][Full Text] [Related]
26. Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function. Kaplan SA Urology; 2004 Mar; 63(3):428-34. PubMed ID: 15028431 [No Abstract] [Full Text] [Related]
27. [Advances in minimally invasive treatment of benign prostatic hyperplasia]. Yu B; Wang Z Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological options in the treatment of benign prostatic hyperplasia. Kenny B; Ballard S; Blagg J; Fox D J Med Chem; 1997 Apr; 40(9):1293-315. PubMed ID: 9135028 [No Abstract] [Full Text] [Related]
31. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997. Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823 [TBL] [Abstract][Full Text] [Related]
32. Finasteride in benign prostatic hyperplasia. Verhamme KM; Bosch RJ; Sturkenboom MC N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034 [No Abstract] [Full Text] [Related]
33. Breakthrough treatment for prostate enlargement. Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):3, 7. PubMed ID: 12712965 [No Abstract] [Full Text] [Related]
34. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. Yu X; Elliott SP; Wilt TJ; McBean AM J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180 [TBL] [Abstract][Full Text] [Related]
35. [Update on current care guidelines: benign prostatic hyperplasia]. Tammela T; Nurmi M; Pétas A; Sipilä R; Taari K Duodecim; 2012; 128(10):1046-7. PubMed ID: 22724320 [TBL] [Abstract][Full Text] [Related]
36. Treatment options in benign prostatic hypertrophy. Stone NN Hosp Pract (Off Ed); 1992 Oct; 27(10A):85-8, 91-2. PubMed ID: 1383248 [TBL] [Abstract][Full Text] [Related]
37. [Variation in the diagnosis and treatment of benign prostatic hyperplasia in urological practice]. Stoevelaar HJ; van de Beek C; Casparie AF; Nijs HG; McDonnell J; Janknegt RA Ned Tijdschr Geneeskd; 1996 Apr; 140(15):837-42. PubMed ID: 8668278 [TBL] [Abstract][Full Text] [Related]
40. Assessment, diagnosis and management of lower urinary tract symptoms in men. Brown CT; Das G Int J Clin Pract; 2002 Oct; 56(8):591-603. PubMed ID: 12425369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]